Developing world gets tiny share of cancer spend

DUBLIN,  (Reuters) – The developing world sees only 5  percent of the world’s spending on cancer treatment, despite  accounting for around half of new cases and nearly two-thirds of  cancer deaths, a report published on Monday said.

The incidence of cancer, once thought to be a disease of the  affluent, is rising in poor countries, and there is an estimated  $217 billion shortfall in funding for cancer treatment globally,  according to a report by the Economist Intelligence Unit.

The study estimated that the economic burden of new cancer  cases would reach $305 billion this year, and that by 2020 there  would be 16.8 million new cancer cases a year worldwide,  compared to 12.9 million now.

The report was released by the Lance Armstrong Foundation,  set up by the seven-times winner of the Tour de France after his  own battle with testicular cancer.

Speaking at a global cancer conference organised by the  foundation in Dublin, Irish Health Minister Mary Harney said she  would seek a total ban on sunbeds to reduce the risk of skin  cancer.

“Clearly, any decisions we make here will have to get EU  approval,” she said. “It may well be that, in the interests of  public health, such approval could be forthcoming.”